Market Overview

Janney Capital Initiates Coverage on Aegerion Pharmaceuticals, Inc. at Buy, Announces $30.00 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for AEGR

DateFirmActionFromTo
Aug 2014Deutsche BankMaintainsBuy
May 2014Goldman SachsInitiates Coverage onSell
May 2014Cowen & CompanyDowngradesOutperformMarket Perform

View More Analyst Ratings for AEGR
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (AEGR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters